Sunday, 26 February 2012
Reduce Brain Bleeding Risks with New Anti-Clotting Drug
Medical Field is ever changing, every other day researchers come up with new findings and improved ways which cure many diseases and enable people to live a healthy and happy life. Atrial Fibrillation (Abnormal Heart Beat) has become very common and researchers are very keen to discover medicines which can help patients in a better and risk-free way. Researchers conducted a study and compare Rivaroxaban and Warfarin, most commonly Physicians suggest these medicines to patients in order to prevent abnormal heart beat followed by stroke.
Anti-clotting medicines are generally suggested to such patients but in some cases anticoagulants (Commonly known as Blood Thinners) enhance risk of bleeding in brain because when blood becomes too thin clotting is badly affected.
Patients of Atrial Fibrillation will be happy to know that an alternate medicine has been introduced by researchers which will reduce risks of Brain Bleeding. Dr. Ken Uchino, program director of the Vascular Neurology Fellowship at the Cleveland Clinic’s Cerebrovascular Center, “All of the newer [blood-thinning] drugs are reported to have lower intracranial bleeding risks than Coumadin [warfarin] when used in the setting of Atrial fibrillation to prevent stroke. This is one advantage, but in absolute terms it is small — on average going from 0.7 percent per year of intracranial bleeding risks to 0.5 percent per year for rivaroxaban — though this is a 33 percent decrease for rivaroxaban.”
The anti-clotting drugs are bit pricey but nothing is more important and valuable than your health. Those who suffer from Atrial Fibrillation must consult their physicians before changing their regular medicines.